RN; BSc; GCert Continuing Care; GDip Coronary Care; PhD
Clinical Research Lead and Deputy Director, the National Centre for Clinical Research on Emerging Drugs (NCCRED). Senior Lecturer, UNSW National Drug and Alcohol Research Centre (NDARC), and St Vincent's Hospital Sydney Centre for Applied Medical Research (SVHS AMR) and Alcohol and Drug Service.
Dr Siefried is an emerging leader in clinical research and clinical trials in populations at risk of harms due to substance use disorders. In her role as Clinical Research Lead and Deputy Director at NCCRED her extensive HIV, Infectious Diseases, Drug and Alcohol, and Public Health experience enable her to direct a program of clinical research and translation; facilitate the establishment of a national clinical research network; and oversee the NCCRED clinical research capacity building grants, seed funding grants, and clinical research fellowships and scholarships.
Dr Siefried has extensive experience in clinical research, healthcare, and clinical project management. Prior leadership roles include: Senior Clinical Project Manager (SVHS AMR); Clinical Research Manager (SVHS AMR Clinical Research Program); and Nurse Unit Manager (Immunology and Infectious Diseases). Prior clinical experience includes Research Nurse and Clinical Trials Coordinator; Registered Nurse / Clinical Nurse Specialist; Heart/Lung Transplant Coordinator; ICU and CCU Registered Nurse (in Australia and Canada).
Broad clinical research interests include comorbidities and treatment outcomes in people living with HIV, and pharmacotherapy for people with methamphetamine dependence.
Other Public and Industry: $1,821,824
St Vincent’s Clinic Foundation Nursing Excellence Award
2016: Clinical Researcher on St Vincent’s Campus
2013-2014: Awarded for research on factors associated with suboptimal outcomes in antiretroviral therapy (CIA)
An open label trial of lisdexamfetamine for acute methamphetamine withdrawal - the OLAM study. ANZCTR: ACTRN12621000045819
Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials. Prospero: CRD42021224850
Exploring social and cultural aspects of GHB use among LGBTQ Australians. Further info.
My Research Supervision
Liam Acheson - Pharmacotherapy for adults during acute withdrawal from methamphetamine (Joint Supervisor with Michael Farrell)
Jack Freestone - Exploring sexualised drug use among LGBTQ populations and examining the impact of peer led interventions to address related harms (Co-Supervisor with Garrett Prestage and Mohamed Hammoud)
Current - UNSW Medicine Hons Project
Vincent Chauvet (2023) - Outcomes and measures used in research of psychedelic medications for mental health and addiction (Co-supervising with Jonathan Brett)
Sophie van der Helder (2023) - Co-designing psychedelic-facilitated psychotherapy studies with Australians with lived experience (Co-supervising with Jonathan Brett)
Completed - UNSW Medicine Hons Project
Keaton Buhagiar (First Class Hons) - Gamma-hydroxybutyrate cultures, experiences and practices in heterosexual cis and transgender people living in Australia (Co-supervised with Jonathan Brett) (2022)
Oliver Harris (First Class Hons) - Gamma-hydroxybutyrate overdose in inner-Sydney emergency departments: a retrospective review (Co-supervised with Jonathan Brett) (2021)
Completed - Notre Dame Medicine Year 2 Research Project
Rhiannon Lindsey - A retrospective audit of gamma-hydroxybutyrate (GHB) withdrawal in an inner-city Sydney hospital (Co-supervised with Jonathan Brett) (2022)
Completed - UNSW Medicine Year 4 Research Project
Amy Healey - Drug use at music festivals (Co-supervised with Jonathan Brett) (2020)
Angus Tolhurst-McKiernan - Methamphetamine use and its associations with insomnia and psychosis (Co-supervised with Nadine Ezard and Jonathan Brett) (2019)
Nursing preceptorships; Clinical Psychology Students (research supervision and clinical supervision); Nursing student supervision (clinical)